CLL14 trial analysis

CLL14: feasibility of fixed-duration frontline therapy in CLLПодробнее

Othman Al Sawaf, ASCO20: Results of the Phase III CLL14 Trial for Chronic Lymphocytic LeukaemiaПодробнее

CLL14 trial: obinutuzumab + venetoclax vs obinutuzumab + chlorambucilПодробнее

Dr. Mato on the CLL14 Trial Results in CLLПодробнее

CLL14: Venetoclax plus obinutuzumab in untreated CLLПодробнее

Dr. Siddiqi on the CLL14 Trial Results in CLLПодробнее

CLL14: Venetoclax plus obinutuzumab for CLLПодробнее

Novel Insights from the Randomized, Phase 3 CLL14 TrialПодробнее

Kirsten Fischer, Treatment of CLL from 2019 Onwards: CLL14 TrialПодробнее

Othman Al-Sawaf, EHA, 2019 – Analysis of the CLL14 trialПодробнее

Venetoclax plus obinutuzumab in CKT CLL: analysis from the CLL14 trialПодробнее

Updates from the CLL14 and CLL2-GiVe trials on CLLПодробнее

Obinutuzumab and venetoclax for high-risk CLL: upcoming CLL14 trialПодробнее

Lori A. Leslie, MD, elaborates on recent outcomes from the CLL14 trialПодробнее

CLL14 trial thoughtsПодробнее

Dr. Shadman on the CLL14 Trial in CLLПодробнее

CLL14 trial: do certain patients benefit more from venetoclax plus obinutuzumab in CLL?Подробнее
